ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Tidal Trust III VistaShares Artificial Intelligence Supercycle ETF

Tidal Trust III VistaShares Artificial Intelligence Supercycle ETF (AIS)

1,62
0,00
(0,00%)
Fermé 06 Janvier 10:00PM
0,00
0,00
(0,00%)
Après les heures de négociation: -

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
1,62
Prix Achat
-
Prix Vente
-
Volume échangé
-
0,00 Fourchette du Jour 0,00
1,62 Plage de 52 semaines 1,62
Clôture Veille
1,62
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume moyen (3 m)
-
Volume financier
-
VWAP
-

AIS Dernières nouvelles

VistaShares Launches its First ETF, Providing Pure Exposure™ to the Artificial Intelligence Supercycle™

Led by Co-Founder Jon McNeill – co-founder of DVx Ventures and former President of Tesla – and CEO Adam Patti – Former Founder and CEO of IndexIQ Focused on solving the major issues with existing...

Skymark Research Initiates Independent Research Coverage on Antares Pharma, Inc.

CALGARY, Alberta, June 18, 2010 (GLOBE NEWSWIRE) -- Skymark Research, a leading provider of small- and micro-cap independent investment research, today initiated coverage on Antares Pharma, Inc...

Dawson James Securities Upgrades Antares Pharma to Strong Buy With $4.00 Price Target

BOCA RATON, Fla., March 16 /PRNewswire/ -- Dawson James Securities, a full-service investment firm covering the healthcare and biotechnology industry, issued an upgrade report raising their...

American Stock Exchange Lists Common Stock of Antares Pharma, Inc.

American Stock Exchange Lists Common Stock of Antares Pharma, Inc. NEW YORK, Sept. 23 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) today listed the common stock of Antares Pharma...

Antares Pharma's (OTCBB: ANTR / Amex: AIS as of September 23, 2004) North American Licensee BioSante Pharmaceuticals, Inc. Annou

Antares Pharma's (OTCBB: ANTR / Amex: AIS as of September 23, 2004) North American Licensee BioSante Pharmaceuticals, Inc. Announces Positive Results of Phase II Study of LibiGel(TM), Topical...

Net Asset Value(s)

RNS Number:2878U Alternative Invest. Strategies Ld 15 January 2004 The unaudited net asset value per ordinary and redeemable ordinary share of the Alternative Investment Strategies Limited...

Holding(s) in Company

RNS Number:6615T Alternative Invest. Strategies Ld 24 December 2003 SCHEDULE 10 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1) Name of company Alternative Investment Strategies...

Final Results

RNS Number:4980T Alternative Invest. Strategies Ld 19 December 2003 ALTERNATIVE INVESTMENT STRATEGIES LIMITED PRELIMINARY ANNOUNCEMENT OF THE FINAL RESULTS The Directors announce...

Net Asset Value(s)

RNS Number:2205T Alternative Invest. Strategies Ld 12 December 2003 The unaudited net asset value per ordinary and redeemable ordinary share of the Alternative Investment Strategies Limited...

Holding(s) in Company

RNS Number:8768S Alternative Invest. Strategies Ld 04 December 2003 SCHEDULE 10 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1) Name of company Alternative Investment Strategies...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1001.621.621.6200SP
4001.621.621.6200SP
12001.621.621.6200SP
26001.621.621.6200SP
52001.621.621.6200SP
156001.621.621.6200SP
260001.621.621.6200SP
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock